This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most sub-disciplines of radiation oncology, including sarcomas and the use of radiation therapy for palliative purposes.

This educational activity will focus on the radiation therapy treatment scenarios commonly faced in practice; i.e., breast radiation for early stage disease undergoing breast conservation and regional nodal irradiation for node positive breast cancer.  Breast radiation following lumpectomy for du

This educational activity will focus on the radiation therapy treatment scenarios commonly faced in practice; i.e., breast radiation for early stage disease undergoing breast conservation and regional nodal irradiation for node positive breast cancer.  Breast radiation following lumpectomy for du

IJROBP Journal SA-CME activity for January 1, 2020 (Volume 106, Issue 1) allows practitioners to integrate new biology into their thinking about the management of localized breast cancer. 

This meeting provides a summary of the most highly-rated abstracts presented at the 2019 Annual Meeting in an informal and interactive format. Presenters connect the science to clinical practice and allow ample time for questions and exchanging ideas with colleagues in the field.

In this session, presenters will discuss the controversies involved in radiotherapy decision-making in the era of neoadjuvant systemic therapy. Data from randomized trials will be described where available, along with the relevant strengths and limitations.

The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear

In this session, presenters will discuss the controversies involved in radiotherapy decision-making in the era of neoadjuvant systemic therapy. Data from randomized trials will be described where available, along with the relevant strengths and limitations.

The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear

With increasing frequency, local therapy in the form of SBRT or hypofractionated radiation is being applied to patients with oligometastatic cancers as a means of attempting to improve survival outcomes, durability of systemic therapy treatment responses, etc.  However, it is apparent that not al